Investments
4Portfolio Exits
2About Merlin BioSciences
Merlin Biosciences Limited is a venture capital firm specializing in life sciences sector with a focus on human medicines or medical devices. It prefers to be an active investor and seeks to take a seat on the board of directors of its portfolio companies. Merlin BioSciences changed its name to Excalibur Fund Managers Limited.
Merlin BioSciences Headquarter Location
Berkeley Square House, Berkeley Square Mayfair
London, England, W1J 6BD,
United Kingdom
Merlin BioSciences Investments
4 Investments
Merlin BioSciences has made 4 investments. Their latest investment was in Neurotech as part of their Series C - II on March 3, 2010.
Merlin BioSciences Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
3/10/2010 | Series C - II | Neurotech | $15M | No | 3i Group, Abenex Capital, AGF Private Equity, Alpha Associates, Altamir Amboise SCR, Apax Partners, Atlas Venture, AVIDA Equity Partners, Banexi Ventures, Banque de Vizille, Burrill & Company, Excalibur Fund Managers, Fondinvest Capital, Gimv, Industrie Management Holding, Nexus Medical Partners, Omega Advisors, Omega Fund Management, Pound Capital, Private Equity Holding AG, Qualium Investissement, Rothschild Gestion, Sofinnova Partners, Sudinnova, SV Health Investors, Triginta Capital, Triginta Capital GmbH, Versant Ventures, and XAnge Private Equity | |
5/4/2007 | Series D | |||||
12/14/1998 | Series B | |||||
Series A |
Date | 3/10/2010 | 5/4/2007 | 12/14/1998 | |
|---|---|---|---|---|
Round | Series C - II | Series D | Series B | Series A |
Company | Neurotech | |||
Amount | $15M | |||
New? | No | |||
Co-Investors | 3i Group, Abenex Capital, AGF Private Equity, Alpha Associates, Altamir Amboise SCR, Apax Partners, Atlas Venture, AVIDA Equity Partners, Banexi Ventures, Banque de Vizille, Burrill & Company, Excalibur Fund Managers, Fondinvest Capital, Gimv, Industrie Management Holding, Nexus Medical Partners, Omega Advisors, Omega Fund Management, Pound Capital, Private Equity Holding AG, Qualium Investissement, Rothschild Gestion, Sofinnova Partners, Sudinnova, SV Health Investors, Triginta Capital, Triginta Capital GmbH, Versant Ventures, and XAnge Private Equity | |||
Sources |
Merlin BioSciences Portfolio Exits
2 Portfolio Exits
Merlin BioSciences has 2 portfolio exits. Their latest portfolio exit was Neurotech on November 12, 2012.